ExodusPoint Capital Management LP purchased a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 183,621 shares of the financial services provider’s stock, valued at approximately $34,065,000.
Several other hedge funds and other institutional investors have also made changes to their positions in MRSH. State Street Corp acquired a new position in shares of Marsh & McLennan Companies during the 4th quarter worth $4,057,682,000. Capital International Investors acquired a new position in Marsh & McLennan Companies in the 4th quarter valued at about $3,482,557,000. Capital World Investors acquired a new position in Marsh & McLennan Companies in the 4th quarter valued at about $3,140,284,000. Norges Bank acquired a new position in Marsh & McLennan Companies in the 4th quarter valued at about $1,555,869,000. Finally, Capital Research Global Investors acquired a new position in Marsh & McLennan Companies in the 4th quarter valued at about $1,481,896,000. Institutional investors and hedge funds own 87.99% of the company’s stock.
Marsh & McLennan Companies Stock Up 0.3%
NYSE MRSH opened at $166.67 on Wednesday. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $220.32. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. The stock has a market cap of $80.52 billion, a PE ratio of 20.83, a P/E/G ratio of 2.42 and a beta of 0.62.
Insider Activity
In other news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on MRSH shares. Barclays cut their target price on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. Wells Fargo & Company cut their target price on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research note on Thursday, April 9th. Mizuho cut their target price on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research note on Monday, April 13th. Piper Sandler cut their target price on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. Finally, UBS Group cut their target price on shares of Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating for the company in a research note on Tuesday, June 9th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Marsh & McLennan Companies has an average rating of “Hold” and a consensus target price of $200.19.
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
- Five stocks we like better than Marsh & McLennan Companies
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
